RNARevive
Biotechnology
Overview
Reprogrammable RNA therapies for regeneration and longevity.. RNARevive is a science-driven biotech developing reprogrammable RNA therapeutics to restore function and support longevity at the molecular and cellular level.
Funding and backers
Backers
1
Plug and Play
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Realizing the potential of tissue-targeted RNA therapies. miRecule™ is a biotechnology company developing RNA therapies for cancer and…
Reverse aging with FOXO's longevity system. Precision diagnostics, personalized data & lifestyle interventions at the cellular level…
Experts in Design and Discovery for RNA Therapeutics | Design custom RNA therapeutics and propel your programs towards the clinic. Let La…
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The…
Immorta Bio is a longevity biotech company developing stem-cell and senescent-cell therapeutics to reverse biological aging and unlock…
Amphix Bio is a preclinical stage company developing a new platform technology, Supramolecular Therapeutic Peptides (STPs), that modifies…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Plug and PlayVia a fund
2741 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely